Evaluation of values and preferences for a novel POC urine LAM test (Fujifilm SILVAMP TB) – a qualitative study
- Conditions
- B20-B24A15-A19Human immunodeficiency virus [HIV] diseaseTuberculosis
- Registration Number
- DRKS00021003
- Lead Sponsor
- niversitätsklinikum Heidelberg Sektion Klinische Tropenmedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Adult aged = 18 years old
Either: (1) Routine healthcare worker participating in either of the two prospective studys on FujilAM and Omega CD4 or (2) Patient or parent of patient tested or to be tested with FujiLAM or Omega CD4 as part of the study or (3) decision maker involved with implementation of novel tests.
Exclusion Criteria
adolescents and parents of patients aged < 18 years, Unable to provide consent
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. To investigate user perspectives on FujiLAM (including perspectives of end- users (such as patients), but also professional users such as laboratory technicians, clinicians, nurses, and decision-makers for use as a diagnostic test in PLHIV<br>2. To investigate and compare experiences and challenges with diagnostic testing for TB in PLHIV using the different diagnostic approaches (FujiLAM, AlereLAM, Xpert, microscopy, culture)<br>3. To understand feasibility and preferences with regard to diagnosing TB in PLHIV and how FujiLAM changes these
- Secondary Outcome Measures
Name Time Method 1. To investigate and compare experiences and challenges with diagnostic testing for TB in children using the different diagnostic approaches (FujiLAM, AlereLAM, Xpert, microscopy, culture)<br>2. To understand feasibility and preferences with regard to diagnosing TB in children and how FujiLAM changes these<br>